1.
Folqué M, Lozano J, Riggioni C, Piquer M, Álvaro M, Machinena A, et al. ‘Real-life’ experience in asthmatic children treated with omalizumab up to six-years follow-up. Allergol Immunopathol [Internet]. 2019 Aug. 15 [cited 2026 Apr. 26];47(4):336-41. Available from: https://www.all-imm.com/index.php/aei/article/view/299